AMBER BLAIR: Open Payments
NPI 1366782781 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194,721 in 406 payments from 18 companies in 2025. Trend: 2023 $95,298 · 2024 $211,252 · 2025 $194,721
Speaker / faculty: $87,140Consulting: $43,583Travel & lodging: $37,835Speaker / faculty: $15,005Food & beverage: $11,138Education: $19
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 49 | $37,078 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 48 | $32,901 |
| Lilly USA, LLC | 58 | $28,301 |
| Arcutis Biotherapeutics, Inc. | 32 | $20,484 |
| Galderma Laboratories, L.P. | 36 | $18,618 |
| LEO Pharma Inc. | 65 | $16,607 |
| E.R. Squibb & Sons, L.L.C. | 30 | $10,937 |
| UCB, Inc. | 28 | $8,916 |
| Incyte Corporation | 22 | $7,047 |
| Novartis Pharmaceuticals Corporation | 9 | $5,412 |
Products named: TREMFYA, Leqselvi, Zoryve, EBGLYSS, NEMLUVIO, ANZUPGO, Sotyktu, Bimzelx.
Industry payments across NC — which companies pay providers there.
